4D pharma PLC | Ownership
Companies that own 4D pharma PLC
Woodford Investment Management Ltd.
16,305,108
24.9%
-1,209,453
0.28%
02/18/2017
Invesco Asset Management Ltd.
9,163,617
13.99%
0
0.03%
08/31/2017
Henderson Global Investors Ltd.
3,425,648
5.23%
1,649,648
0%
06/11/2018
Lansdowne Partners (UK) LLP
3,000,000
4.58%
0
0.05%
12/31/2016
Baillie Gifford & Co.
1,893,000
2.89%
0
0%
06/04/2018
JPMorgan Asset Management (UK) Ltd.
1,225,761
1.87%
0
0%
05/31/2018
Sand Aire Ltd.
606,000
0.93%
-225,000
0.17%
06/04/2018
Ruffer LLP
566,000
0.86%
0
0.01%
06/04/2018
Aviva Investors Global Services Ltd.
437,000
0.67%
-934,000
0%
06/04/2018
Kuwait Investment Authority (Investment Management)
379,000
0.57%
198,000
0.01%
06/04/2018
| Address |
9 Bond Court
Leeds Yorkshire LS1 2JZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://4dpharmaplc.com |
| Updated |
07/08/2019 |
| 4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of MicroRx, its proprietary platform for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded on January 10, 2014 and is headquartered in Leeds, the United Kingdom. |
